Treatment of advanced ALK-rearranged NSCLC following second-generation ALK-TKI failure

Fukuda, A; Yoshida, T

Yoshida, T (通讯作者)，Natl Canc Ctr, Dept Thorac Oncol, Tokyo 1040045, Japan.

EXPERT REVIEW OF ANTICANCER THERAPY, 2023; 23 (11): 1157

Abstract

IntroductionAnaplastic lymphoma kinase (ALK) gene rearrangement is detected in approximately 3-5% of non-small cell lung cancer (NSCLC) cases. Tyrosin......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索